"Women are an under-diagnosed population at risk of heart disease. OBGYNs are recognizing this and implementing comprehensive lipoprotein testing into their practices," Atherotech Chief Medical Officer Michael E. Cobble, M.D., said. "The VAP lipid profile shows the pathophysiology of lipids, so a practitioner can make educated and guided lipid management choices."

Atherotech provides physicians with a single source for the VAP Cholesterol Test and more than a dozen cardiovascular and metabolic tests. Cardiometabolic testing available through Atherotech includes C-Reactive Protein (hsCRP), LpPLA2, apoE genotype, NT-proBNP, Cystatin-C, T3 and T4 when TSH is abnormal, plus gamma-glutamyl transferase (GGT), a recognized cardiovascular risk biomarker.

Atherotech representatives will be available to discuss new research, the VAP Test and cardiometabolic test options throughout the conference. Blood draws will be provided to qualified attendees during regular exhibit hours. Unlike the standard lipid profile, the VAP Test directly measures LDL, therefore fasting is not required.

SOURCE Atherotech Diagnostics Lab